Translational Medicine Analytics

Biomarker screening, diagnostic model analysis, clinical cohort statistics, and multi-omics evidence packaging for translational research.

What this service helps with

Translational researchers needing biomarker discovery pipelines from clinical or omics data.
Clinical study teams requiring statistical analysis, survival curves, and subgroup comparisons.
Grant applicants who need evidence packages to support translational hypotheses.
Teams exploring diagnostic or prognostic model development from retrospective cohorts.

Systematic screening of candidate biomarkers using statistical and machine-learning approaches.

Development and validation of diagnostic scores, risk models, and prediction algorithms with performance metrics.

Descriptive statistics, comparative tests, survival analysis, and subgroup stratification.

Kaplan-Meier curves, Cox regression, and stratified analyses across patient subgroups.

Integration of genomic, transcriptomic, proteomic, or metabolomic data with clinical phenotypes.

Structured compilation of figures, statistics, and interpretation for grant applications or translational reports.

Not necessarily. Many projects start with processed count matrices, clinical tables, or public datasets. Raw data can be handled if available.

Yes. All clinical data should be de-identified before sharing. No protected health information is required.

Standard biostatistical methods including survival analysis, regression modeling, ROC analysis, and machine-learning classification as appropriate.

Yes. Translational evidence packages are designed for inclusion in grant proposals, IRB submissions, and translational study reports.

For research and translational decision support only. Not a substitute for clinical diagnosis, treatment advice, or regulatory compliance review.